Dengue Fever
Every year
3.9 Billion
world population
at risk of Dengue
infections
400 Million
people have Dengue infections
500,000
people progressed on to
develop Severe Dengue and
required hospitalization
20,000
of the Severe Dengue patients die from the disease
2 Billion
more people at risk of Dengue infection by 2080
US$14.6 Billion
worth of socioeconomic cost
67%
reduction of hospitalization
burden by StratifiDen
Do you know?
Only patients who develop Severe Dengue require hospital monitoring
Patients not at risk of Severe Dengue can be managed at outpatient settings
However, due to the lack of a prediction test, physicians can only make clinical judgement based on warning signs shown by the patient
.png)
Warning signs shown by patient include
-
Abdominal pain or tenderness
-
Persistent vomiting
-
Clinical fluid accumulation
-
Mucosal bleed
-
Lethargy or restlessness
-
Liver enlargment >2 cm
-
Increase in HCT concurrent with rapid decrease in platelet count
The challenge in the clinical management of Dengue is how to accurately predict which patients will go on to develop Severe Dengue in the early phase of the disease.
.png)
Suspected Dengue case
Patient visits the hospital to seek treatment
Patient gets hospitalized if they exhibit 1 or more warning signs
Unnecessary hospitalization as over 50% of hospitalized Dengue patients do not develop Severe Dengue
Increase in unnecessary healthcare expenses
With the introduction of a Severe Dengue prediction test, we are able to determine the risk of Severe Dengue development.
Suspected Dengue case
Patient visits the hospital to seek treatment
Use of Severe Dengue prediction test
Patient gets hospitalized if predicted to develop Severe Dengue
More focused medical attention and aggressive supportive treatment on patients with Severe Dengue
Patient gets triaged to outpatient care if predicted not to develop Severe Dengue
Avoid unnecessary hospitalization
Reduced unnecessary healthcare expenses